Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Allogene Therapeutics, Inc. (ALLO)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 140,280,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Allogene Therapeutics is a clinical stage immuno-oncology company focused on the development of genetically engineered allogeneic T cell therapies for the treatment of cancer. Co.'s key product candidates, ALLO-501 and ALLO-501A, are engineered allogeneic Chimeric antigen receptor (CAR) T cell therapies that target CD19, a protein expressed on the cell surface of B cells and a validated target for B cell driven hematological malignancies. Co. is also developing engineered allogeneic CAR T cell product candidates for multiple myeloma, clear cell renal cell carcinoma, and other blood cancers and solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 190 190 190
Total Buy Value $0 $683 $683 $683
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 0 18,640 28,640 82,742
Total Sell Value $0 $50,317 $93,172 $700,150
Total People Sold 0 1 2 5
Total Sell Transactions 0 1 2 12
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 103
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Amado Rafael EVP of R&D and CMO   •       –      –    2021-03-26 4 A $0.00 $0 D/D 24,866 134,901     -
   Schmidt Eric Thomas Chief Financial Officer   •       –      –    2021-03-26 4 A $0.00 $0 D/D 24,866 96,097     -
   Belldegrun Arie   –       •      –    2021-03-26 4 A $0.00 $0 D/D 53,635 203,968     -
   Chang David D President and CEO   •       •      –    2021-03-26 4 A $0.00 $0 D/D 80,452 2,284,869     -
   Bhavnagri Veer General Counsel   •       –      –    2021-03-26 4 A $0.00 $0 D/D 22,202 421,353     -
   Moore Alison Chief Technical Officer   •       –      –    2021-03-15 4 S $38.14 $235,089 D/D (6,164) 102,574     -
   Schmidt Eric Thomas Chief Financial Officer   •       –      –    2021-03-15 4 S $38.23 $307,889 D/D (8,053) 71,231     -
   Chang David D President and CEO   •       •      –    2021-03-15 4 S $38.57 $791,271 D/D (20,513) 2,204,417     -
   Bhavnagri Veer General Counsel   •       –      –    2021-03-15 4 AS $37.79 $630,798 D/D (16,623) 399,151     -
   Bhavnagri Veer General Counsel   •       –      –    2021-03-15 4 OE $2.27 $22,700 D/D 10,000 415,774     -
   Amado Rafael EVP of R&D and CMO   •       –      –    2021-03-15 4 S $38.05 $106,471 D/D (2,798) 110,035     -
   Schmidt Eric Thomas Chief Financial Officer   •       –      –    2021-01-15 4 AS $31.69 $483,859 I/I (15,000) 1,152,595     -
   Schmidt Eric Thomas Chief Financial Officer   •       –      –    2021-01-14 4 AS $30.60 $461,610 I/I (15,000) 1,167,595     -
   Bhavnagri Veer General Counsel   •       –      –    2020-12-17 4 OE $2.27 $116,905 D/D 51,500 405,402     -
   Schmidt Eric Thomas Chief Financial Officer   •       –      –    2020-11-16 4 AS $32.60 $493,146 I/I (15,000) 1,182,595     -
   Schmidt Eric Thomas Chief Financial Officer   •       –      –    2020-10-15 4 AS $39.47 $607,392 I/I (15,000) 1,197,595     -
   Moore Alison Chief Technical Officer   •       –      –    2020-10-13 4 AS $42.00 $463,302 D/D (11,031) 108,370     -
   Moore Alison Chief Technical Officer   •       –      –    2020-10-13 4 OE $2.27 $25,040 D/D 11,031 119,401     -
   Moore Alison Chief Technical Officer   •       –      –    2020-10-12 4 AS $42.00 $1,017,786 D/D (24,233) 108,370     -
   Moore Alison Chief Technical Officer   •       –      –    2020-10-12 4 OE $2.27 $55,009 D/D 24,233 132,603     -
   Moore Alison Chief Technical Officer   •       –      –    2020-10-09 4 AS $41.00 $1,619,869 D/D (39,509) 108,370     -
   Moore Alison Chief Technical Officer   •       –      –    2020-10-09 4 OE $2.27 $68,552 D/D 30,199 147,879     -
   Moore Alison Chief Technical Officer   •       –      –    2020-10-08 4 AS $41.00 $207,665 D/D (5,065) 117,680     -
   Moore Alison Chief Technical Officer   •       –      –    2020-10-08 4 OE $2.27 $11,498 D/D 5,065 122,745     -
   Amado Rafael EVP of R&D and CMO   •       –      –    2020-10-07 4 AS $39.40 $651,515 D/D (16,538) 111,677     -
  103 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us